422 The mode of action of CYC202 (R-roscovitine) a cyclin dependent kinase inhibitor currently in phase II clinical trials

S. Green; D.E. MacCallum; I.N. Fleming; J. Melville; M. Watson; S. Frame; K. Watt; S. Anderson; A. Gianella-Borradori; D.P. Lane

作者S. Green; D.E. MacCallum; I.N. Fleming; J. Melville; M. Watson; S. Frame; K. Watt; S. Anderson; A. Gianella-Borradori; D.P. Lane
卷第2卷
期第8期
文件大小125.95KB
发表时间2004
DOI10.1016/s1359-6349(04)80430-0

发现好书期刊，享受阅读乐趣